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Multiple trials have shown the benefit of endovascular recanalization therapy in selected stroke patients.1–3 
Earlier treatment is associated with better functional out-
come.4 The time from symptom onset to treatment is influ-
enced by prehospital and in-hospital processes. Healthcare 
systems are being reorganized to offer stroke patients rapid 
and effective medical care. Stroke services had already 
changed their workflow since intravenous tPA (tissue-type 
plasminogen activator) for selected stroke patients was proven 
effective.5 Implementation of new strategies to improve the 
workflow process for treatment with intravenous tPA has led 
to a significant reduction of in-hospital delay.6
Providing an optimal diagnostic process and rapid endo-
vascular stroke treatment requires close collaboration of the 
emergency medical service, emergency department team, 
stroke team, neurointerventional team, and anesthesia team. 
Diagnostic imaging and endovascular treatment facilities 
should be available in little time. Several strategies to re-
duce the time to endovascular stroke treatment have been 
proposed.7–9 However, the effect of individual and combined 
strategies on reducing time to treatment is unclear. We per-
formed a systematic review and meta-analysis on the effec-
tiveness of specific workflow improvement interventions for 
rapid delivery of endovascular stroke treatment.
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Background and Purpose—Rapid initiation of endovascular stroke treatment is associated with better clinical outcome. 
The effect of specific improvements is not well known. We performed a systematic review and meta-analysis on the 
effectiveness of specific workflow improvements on time to treatment and outcome.
Methods—A random-effects meta-analysis was used to evaluate the difference in mean time to treatment between 
intervention group and control group. Secondary outcomes included good functional outcome at 90 days (modified 
Rankin Scale score 0–2).
Results—Fifty-one studies (3 randomized controlled trials, 13 prepost intervention studies, and 35 observational studies) 
with in total 8467 patients were included. Most frequently reported workflow intervention types concerned anesthetic 
management (n=26), in-hospital patient transfer management (n=14), and prehospital management (n=11). Patients in 
the intervention group had shorter time to treatment intervals (weighted mean difference, 26 minutes; 95% CI, 19–33; 
P<0.001) compared with controls. Subgroup meta-analysis of intervention types also showed a shorter time to treatment 
in the intervention group: a mean difference of 12 minutes (95% CI, 6–17; P<0.001) for anesthetic management, 37 
minutes (95% CI, 22–52; P<0.001) for prehospital management, 41 minutes (95% CI, 27–54; P<0.001) for in-hospital 
patient transfer management, 47 minutes (95% CI, 28–67; P<0.001) for teamwork, and 64 minutes (95% CI, 24–104; 
P=0.002) for feedback. The mean difference in time to treatment of studies with multiple interventions implemented 
simultaneously was 50 minutes (95% CI, 31–69; P<0.001) in favor of the intervention group. Patients in the intervention 
group had increased likelihood of favorable outcome (risk ratio [RR], 1.39; 95% CI, 1.15–1.66; P<0.001).
Conclusions—Interventions in the workflow of endovascular stroke treatment lead to a significant reduction in time to 
treatment and results in an increased likelihood of favorable outcome. Acute stroke care should be reorganized by 
making use of the examples of workflow interventions described in this review to ensure the best medical care for stroke 
patients.   (Stroke. 2019;50:665-674. DOI: 10.1161/STROKEAHA.118.021633.)
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Methods
This systematic review and meta-analysis was performed according 
to the Preferred Reporting Items for Systematic Review and Meta-
Analysis guidelines.10 All data and supporting materials are available 
within the article and its online-only Data Supplement.
Search Strategy
Medline, EMBASE, Cochrane Central, and Web of Science were 
searched for studies that evaluated the effect of ≥1 workflow inter-
ventions on time to endovascular stroke treatment, from database in-
ception to November 14th, 2017. Google Scholar and Google were 
searched on November 14th, 2017, and the first 200 hits were in-
cluded. We developed a broad search strategy consisting of a combi-
nation of the 2 main topics of this study: endovascular stroke treatment 
and workflow intervention. The complete search strategy is available 
in the online-only Data Supplement. We restricted our search to stud-
ies published in English and excluded conference abstracts.
Eligibility Criteria
Studies were included if ≥1 (prehospital or in-hospital) interven-
tions in the workflow of endovascular stroke treatment were assessed 
and effect on time to treatment intervals was reported. Endovascular 
stroke treatment was defined as mechanical thrombectomy or intra-
arterial fibrinolysis in an acute stroke patient with an intracranial 
large vessel occlusion. Interventions only aimed at the duration of the 
endovascular treatment itself, for example, type of mechanical throm-
bectomy device used, were excluded. Interventions intended only to 
increase the accuracy of patient selection, for example, the introduc-
tion of a new imaging protocol, were also excluded. Studies were 
included in the systematic review when time to endovascular treat-
ment was reported from symptom onset to start treatment or any time 
window between symptom onset and start treatment. Randomized 
and nonrandomized controlled trials and prepost intervention stud-
ies were included. Observational studies or post hoc analyses of ob-
servational data in trials were only included when a control group 
was reported. Reviews, editorials, and guidelines were excluded. Two 
authors (Drs Janssen and Venema) independently assessed the eligi-
bility of all retrieved studies. Title and abstracts were first screened 
to identify potentially eligible articles and then full texts were read to 
confirm inclusion. Reference lists of identified eligible articles and 
review articles were scanned for additional relevant studies.
Risk of Bias Assessment
The risk of bias of each included study was assessed against the fol-
lowing key criteria: random sequence generation; allocation conceal-
ment; blinding of participants, personnel, and outcomes; incomplete 
outcome data; and selective outcome reporting; in accordance with 
the methods recommended by the Cochrane Library.11 The follow-
ing judgments were used: low risk, high risk, or unclear risk of bias 
(either lack of information or uncertainty on the potential for bias). 
Summary of risk of bias per key criterion was provided for all in-
cluded articles separately.
Data Extraction and Outcome Variables
Data were extracted from published reports by 2 authors (Drs Janssen 
and Venema). Workflow interventions were described and divided 
into 6 predefined categories: (A) anesthetic management, (B) prehos-
pital management, (C) in-hospital patient transfer management, (D) 
teamwork, (E) feedback, and (F) other workflow interventions. Other 
collected data on study characteristics included study design, study 
period, stroke type (anterior or posterior circulation stroke, or both), 
and sample size.
The primary outcome measure in this study was the difference 
in time to treatment between the intervention group and control 
group. Other study outcomes were good functional outcome, defined 
as modified Rankin Scale score 0 to 2 at 90 days after endovascular 
treatment, symptomatic intracranial hemorrhage, and mortality.
Statistical Analysis
Mean time to treatment with SD for the intervention group and con-
trol group was retrieved from each included study. When mean values 
with SD were not available in the publication nor obtained from the 
authors of the original publication, we used reported median time to 
treatment with interquartile range to estimate the sample mean and 
SD using the method described by Wan et al.12 The absolute differ-
ence of mean time to treatment with 95% CIs was calculated for each 
study using a 2-sample t test.
Studies were included in the meta-analysis when mean time to 
treatment with SD or median time to treatment with interquartile 
range was available for both groups. Weighted difference in mean 
time to treatment with 95% CI was calculated using a random-effects 
inverse variance model, with the estimate of heterogeneity being 
taken from the Mantel-Haenszel model. Subgroup analysis of the dif-
ference in mean time to treatment was performed for the predefined 
workflow intervention categories A to E and for studies implementing 
multiple interventions simultaneously.
Data on binary outcomes (good functional outcome, sympto-
matic intracranial hemorrhage, and mortality) were pooled using 
random-effects meta-analysis and expressed as RRs. Publication 
bias was assessed by constructing a funnel plot. All statistical analy-
ses were conducted with Stata, version 15 (Statacorp LLC, College 
Station, TX).
Results
Our literature search identified 4127 potentially relevant 
unique articles; 211 articles were retained for full-text review 
(Figure 1). A total of 51 studies met the inclusion criteria and 
were included in the qualitative synthesis.2,13–62 We contacted 
authors from 31 of 51 studies with requests for additional data 
necessary for our meta-analysis. These additional data were 
provided for 17 of 31 studies. The sample mean difference in 
time to treatment with SD could be estimated from published 
data from 8 of 31 studies. After exclusion of the remaining 6 
studies because of lack of sufficient data, a total of 45 studies 
was included in the meta-analysis on effect of workflow inter-
ventions on the time to treatment.
Fifty-one studies with 8467 patients (4037 intervention 
group and 4430 control group) reported the effect of 25 differ-
ent workflow interventions on the time to endovascular treat-
ment (Tables 1 and 2). Two studies reported the effect on time 
to treatment of 2 interventions separately.50,55 Most frequently 
reported workflow intervention types concerned anesthetic 
management (n=26), in-hospital patient transfer management 
(n=14), and prehospital management (n=11). Ten studies re-
ported the effect on time to treatment of multiple interventions 
implemented simultaneously. Time to treatment was shorter 
in the intervention group in 48 of 53 interventions (91%) re-
ported in the 51 included studies. Included studies differed 
in study design, with 3 studies randomizing patients for the 
workflow intervention of interest in our study, 13 prepost in-
tervention studies, and the remaining 35 studies reporting 
observational data mostly from hospital stroke registries or 
randomized controlled trials investigating the effect of endo-
vascular stroke treatment versus conservative treatment. Data 
collection was performed retrospectively in 34 studies, and 16 
studies collected data from ≥1 center. Assessment of risk of 
bias is available in the online-only Data Supplement.
Random-effects meta-analysis of 45 studies (with 47 inter-
ventions), including 7482 patients (3480 intervention group 
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treatment of 26 minutes (95% CI, 19–32; P<0.001) in favor of 
the intervention group (Figure 2). I2 value was 85.4%, and χ2 
value was 314.87 (df, 46; P<0.001), indicating considerable 
heterogeneity between studies.
The mean time to treatment was shorter in the interven-
tion group compared with controls in the predefined workflow 
intervention categories (Table 3). The weighted difference 
in mean time to treatment was 12 minutes (95% CI, 6–17; 
P<0.001) for anesthetic management, 37 minutes (95% CI, 
22–52, P<0.001) for prehospital management, 41 minutes 
(95% CI, 27–54, P<0.001) for in-hospital patient transfer 
management, 47 minutes (95% CI, 28–67, P<0.001) for team-
work, and 64 minutes (95% CI, 24–104, P=0.002) for feed-
back. The weighted difference in mean time to treatment of 
studies with multiple interventions implemented simultane-
ously was 50 minutes (95% CI, 31–69, P<0.001) in favor of 
the intervention group. Forest plots of the difference in mean 
time to treatment for each type of workflow intervention are 
available in the online-only Data Supplement. The description 
of used time intervals in the studies, mean (SD) estimates for 
each study group, and a subgroup analysis per time interval is 
provided in the online-only Data Supplement.
Twenty studies reported the occurrence of favorable out-
come, defined as score 0–2 on the modified Rankin Scale at 
90 days (in the online-only Data Supplement). Meta-analysis 
showed that patients in the intervention group had a higher 
likelihood of favorable outcome (absolute risk difference, 
12.2%; RR, 1.39; 95% CI, 1.15–1.66; P<0.001) in compar-
ison with controls. Data from 21 studies reporting the prev-
alence of symptomatic intracranial hemorrhage showed no 
difference between patients in the intervention groups and 
controls (RR, 0.88; 95% CI, 0.71–1.09; P=0.239). Mortality 
was assessed in 25 studies. Twelve studies reported in-hospital 
mortality, 2 studies reported mortality at 30 days, and 11 stud-
ies reported mortality at 3 months. Patients in the intervention 
groups had a lower risk of overall mortality (absolute risk dif-
ference, 7.4%; RR, 0.74; 95% CI, 0.63–0.87; P<0.001) com-
pared with controls.
We found no evidence of potential publication bias in the 
funnel plot that was constructed after exclusion of 2 studies 
with a very large absolute difference in time to treatment be-
tween intervention group and controls (Figure 3).34,36
Discussion
Our systematic review and meta-analysis showed that inter-
ventions in the workflow of endovascular treatment for acute 
ischemic stroke led to a significant reduction in time to treat-
ment. This applied to all categories of studied interventions, 
which were interventions aimed at using local anesthesia or 
conscious sedation, optimizing prehospital management, re-
ducing in-hospital patient transfer, improving teamwork, and 
supplying feedback on achieved time intervals to the team. 
These workflow interventions led to higher likelihood of fa-
vorable functional outcome after 3 months.
The favorable effect of workflow interventions on the time 
to treatment is consistent with previous studies, including acute 
stroke patients treated with intravenous tPA. Implementation 
of a national quality improvement initiative organized by the 
American Heart Association/American Stroke Association, 
including >70 000 patients, resulted in significantly shorter 
door-to-needle time and significantly higher percentage of 
patients treated with intravenous tPA within 60 minutes.63 
Figure 1. Flowchart of included and excluded 
articles, following the Preferred Reporting Items 
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Table 1. Studies Included in Systematic Review











Abou-Chebl et al13 United States Retrospective cohort study; multicenter 2005–2009 Anterior 552 428 A
Abou-Chebl et al14 United States Post hoc analysis retrospective NASA 
Registry; multicenter
2012–2013 Both 68 159 A
Abou-Chebl et al15 Canada, Europe, 
United States
Post hoc analysis IMS III trial; multicenter 2006–2012 Both 269 147 A
Aghaebrahim 
et al16
United States Prospective prepost study; single center 2012–2013/
2013–2014
Both 108 178 B1, C1–3, 
D1–2, E1, F1
Alotaibi et al17 Canada Retrospective prepost study; single center 2011–2014/
2014–2016
Both 28 17 E2
Van den Berg 
et al18
The Netherlands Retrospective cohort study; multicenter 2002–2010 Anterior 278 70 A
Berkhemer et al19 The Netherlands Post hoc analysis MR CLEAN trial; multicenter 2010–2014 Anterior 137 79 A
Bracard et al2 France Post hoc analysis THRACE trial; multicenter 2010–2014 Both 74 69 A
Cerejo et al20 United States Retrospective cohort study; single center 2014 Anterior 5 5 B2
Davis et al21 Canada Retrospective cohort study; single center 2003–2009 Both 37 39 A
Eesa et al22 Canada Retrospective cohort study; single center 2005–2009 Both 71 30 A
Frei et al23 United States Retrospective prepost study; single center 2012–2013/
2013–2015
Both 267 113 B1, D2–4, 
F1–3
Goyal et al24 Canada, Europe, 
United States
Post hoc analysis IMS III trial; multicenter 2006–2012 Both 17 64 B3
Goyal et al25 Europe, United 
States
Post hoc analysis SWIFT PRIME trial; 
multicenter
2012–2014 Anterior 61 35 A
Hassan et al26 United States Retrospective cohort study; multicenter 2006–2010 Both 83 53 A
Henden et al27 Sweden Randomized controlled trial; single center 2013–2016 Anterior 45 45 A
Herrmann et al28 Germany Prepost study; retrospective data 




Both 23 48 F4
Jadhav et al29 United States Retrospective cohort study; single center 2013–2016 Both 111 150 C2
Jagani et al30 United States Retrospective cohort study; single center 2008–2015 Both 61 38 A
Janssen et al31 Germany Retrospective cohort study; single center 2012–2014 Anterior 31 53 A
Jeon et al32 Korea Retrospective prepost study; single center 2014–2016/
2016
Not specified 19 93 B1, C3, D2, 
E1, F1-2
John et al33 United States Retrospective cohort study; single center 2008–2012 Anterior 99 91 A
Jumaa et al34 United States Retrospective cohort study; single center 2006–2009 Anterior 73 53 A
Just et al35 Canada Retrospective cohort study; single center 2000–2013 Both 67 42 A
Kamper et al36 Germany Retrospective prepost study; single center 2002–2006/
2007–2010
Posterior 20 18 F5
Koge et al37 Japan Retrospective prepost study; single center 2008–2014/
2014–2016
Not specified 23 19 D3–4, E1
Komatsubara 
et al38
Japan Prepost study; retrospective or prospective 
data collection not specified; single center
2012–2014/
2014–2015
Both 14 14 E1, F1, F6
Li et al39 United States Retrospective cohort study; single center 2006–2012 Both 74 35 A
Liang et al40 United States Retrospective cohort study; single center 2015–2016 Not specified 22 17 B4
Mascitelli et al41 United States Retrospective prepost study; single center 2014/
2014–2015
Both 29 27 B1, E1–2, F1
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Workflow improvement strategies were promoting prenotifi-
cation of hospitals by emergency medical service, rapid ac-
tivation of the entire stroke team, rapid acquisition of brain 
imaging, and provision of feedback to the stroke team on per-
formance. A single center study showed that the introduction 
of multiple concurrent strategies aimed at reducing in-hospital 
delay in treatment of acute stroke patients with intravenous 
tPA led to a remarkable time reduction and final median door-
to-needle of 20 minutes.6
Our results are also consistent with studies on workflow 
improvement for reperfusion treatment of patients with my-
ocardial infarction with ST-segment elevation. A study on 
time-saving strategies in the workflow for patients with acute 
myocardial infarction, including 365 hospitals, showed that 
Mehta et al43 United States Prepost study; retrospective data 




Anterior 51 93 C3, D2–4




Prespecified secondary analysis ESCAPE 
trial; multicenter
2013–2014 Anterior 136 15 A
Miley et al45 United States Retrospective cohort study; multicenter 2005–2008 Both 52 39 A
Mundiyanapurath 
et al46
Germany Prospective cohort study; single center 2013–2014 Both 15 29 A
Nichols et al47 United States Post hoc analysis IMS II trial; multicenter 2003–2006 Anterior 40 17 A
Pedragosa et al48 Spain Prospective cohort study; multicenter 2008–2010 Not specified 25 20 B6
Pfaff et al49 Germany Prospective cohort study with historical 
controls; single center
2014 Both 3 16 C4
Pfaff et al50 Germany Prospective cohort study with historical 
controls; single center
2014–2016 Anterior 22 28 A
Pfaff et al50 Germany Prospective cohort study with historical 
controls; single center
2014–2016 Anterior 28 28 C4
Psychogios et al51 Germany Retrospective cohort study; single center 2016 Not specified 30 44 C4
Qureshi et al52 United States Retrospective cohort study; multicenter 2007–2012 Not specified 66 117 C3
Ragoschke et al53 Germany Prepost study; retrospective data 




Both 174 81 C5
Rai et al54 United States Prospective prepost study; single center 2011–2014/
2015
Both 30 64 B1, D2–4, F2
Ribo et al55 Spain Retrospective cohort study; single center 2015–2016 Not specified 74 87 C1
Ribo et al55 Spain Retrospective cohort study; single center 2015–2016 Not specified 40 87 C2
Schonenberger 
et al56
Germany Randomized controlled trial; single center 2014–2016 Anterior 77 73 A
Schregel et al57 Germany Retrospective prepost study; single center 2008–2014/
2014–2015
Both 90 278 C3, D2, E1
Simonsen et al58 Denmark Randomized controlled trial, single center 2015–2017 Anterior 63 65 A
Singer et al59 Austria, Germany Post hoc analysis ENDOSTROKE registry; 
both retrospective and prospective data 
collection; multicenter
2011–2012 Both 36 691 A
Slezak et al60 Switzerland Prospective cohort study; single center 2010–2015 Anterior 135 266 A
Sugg et al61 United States Retrospective cohort study; single center 2007–2009 Both 57 9 A
Tsujimoto et al62 Japan Retrospective cohort study; single center 2011–2013 Both 6 16 B7
ENDOSTROKE, Endovascular Stroke Treatment; ESCAPE, Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on 
Minimizing CT to Recanalization Times; IMS, Interventional Management of Stroke; MR CLEAN, Multicenter Randomized Clinical Trial of Endovascular Treatment for 
Acute Ischemic Stroke in the Netherlands; NASA, North American Solitaire Stent-Retriever Acute Stroke; SWIFT PRIME, Solitaire With the Intention for Thrombectomy as 
Primary Endovascular Treatment for Acute Ischemic Stroke; and THRACE, Thrombectomie des Artères Cerebrales.
*Study period for pre/postintervention group.
Table 1. Continued
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rapid activation and availability of the entire team and use of 
real-time data feedback by the staff in the emergency depart-
ment and angiography suite, reduced mean door-to-balloon 
time with 8 to 19 minutes.64
The workflow interventions in this review can easily be 
implemented in any intervention center. A time-saving effect 
of >1 hour could be achieved by providing feedback on time 
intervals to the entire team. Implementation of regular feedback 
in the 4 included studies in this meta-analysis was executed by 
supplying time intervals and outcome to the entire team daily 
using an online bulletin or email, reviewing each patient during 
weekly or monthly meetings, or comparing actually achieved 
times to target times every 3 months.32,37,41,57 Evaluation of time 
intervals can simply be added to existing regular meetings at 
intervention hospitals. Optimizing in-hospital teamwork by 
using parallel processing instead of sequential processing in the 
workflow, and by early activation of all team members, requires 
multidisciplinary protocols or standard operating procedures. 
The time-investment to draft and implement such protocols 
seems well worthwhile because our meta-analysis showed a 
mean time reduction of 47 minutes.23,32,37,42,43,54,57 Effects of mul-
tiple interventions cannot be simply added, but implementing 
multiple interventions at the same time still led to a very large 
time reduction of 50 minutes and is probably preferred above 
implementing 1 intervention at a time.
Figure 2. Forest plot of weighted difference in mean time to treatment for 
workflow interventions in endovascular stroke treatment, using random-
effects meta-analysis
Table 2. Categories of Workflow Interventions in Endovascular Stroke Treatment
Anesthetic Management
  A=Nongeneral anesthesia vs general anesthesia
Prehospital Management*
  B1=Prenotification ED team, CT technologist, and stroke team by EMS
  B2=Mobile stroke treatment unit with CT scanner, point of care 
laboratory testing, vascular neurologist available via telemedicine
  B3=Ship and drip for transfer patients vs drip and ship
  B4=CTA at PSC vs at CSC
  B5=Cloud based image sharing between PSC and CSC
  B6=Use of telemedicine assessment by a stroke neurologist at PSC
  B7=Air transfer vs ground transfer
In-hospital Patient Transfer
  C1=Transporting patients directly to CT scanner by EMS
  C2=Transporting (transfer) patients directly to angiosuite by EMS
  C3=No turn around approach (not returning to ED after imaging for 
decision-making)
  C4=Single room used for CT, angiography, and EVT
  C5=Single room for patient evaluation, CT, angiography, and EVT
Teamwork
  D1=Early communication between ED team and stroke team about plan 
of care
  D2=Early activation neurointerventional team
  D3=Parallel processing from ED/hospital ward to CT: clinical 
assessment, laboratory tests, imaging, patient/family education by the 
teams in a parallel workflow
  D4=Parallel processing from CT to angiosuite: neurointerventional 
team meets patient at CT, teams evaluate CT/CTA and make treatment 
decision while angiosuite is set up, patient/family education
Feedback
  E1=Education and feedback all teams
  E2=Smartphone application/digital system for real-time window from 
stroke onset to puncture for all teams, visualizing performance metrics
Other
  F1=Limiting nonessential interventions (eg, ECG, chest X-ray, additional 
venous access, bladder catheter placement)
  F2=Standard angiography set for all of the devices needed for EVT
  F3=No groin shaving
  F4=Standard operating procedure for intubation at the intensive care 
unit before EVT
  F5=Standard operating procedure for EVT
  F6=Not waiting for effect IV tissue-type plasminogen activator vs waiting 
for 1 h
CT indicates computed tomography; CTA, computed tomography 
angiography; CSC, comprehensive stroke center; ED, emergency department; 
EMS, emergency medical service; EVT, endovascular treatment; IV, intravenous; 
and PSC, primary stroke center.*Prehospital management includes all 
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Anesthetic management in endovascular stroke treatment 
is a much-discussed topic because it possibly influences both 
time to treatment intervals as cerebral perfusion and thereby 
indirect functional outcome. A meta-analysis, including 
4716 patients undergoing endovascular stroke treatment, 
showed a difference in time to treatment of 14 minutes in 
favor of patients receiving local anesthesia or conscious se-
dation compared with general anesthesia and a higher odds 
of good functional outcome.65 Which studies were used for 
comparing time to treatment by type of anesthesia manage-
ment and the way missing data was handled was not dis-
closed. Our meta-analysis included additional studies on 
anesthetic management and showed a comparable difference 
in time to treatment of 12 minutes in favor of patients re-
ceiving local anesthesia or conscious sedation. Both meta-
analyses included many observational studies with possible 
selection bias. Only 3 randomized controlled trials, random-
izing patients for local anesthesia or conscious sedation 
versus general anesthesia, were included in our meta-anal-
ysis, showing a nonsignificant difference in treatment inter-
vals in 2 studies,27,58 and a significant difference in time to 
treatment in 1 study of 10 minutes in favor of conscious se-
dation (95% CI, 2–18).56 We did not find studies comparing 
conscious sedation with local anesthesia. Regarding anes-
thetic management in endovascular stroke treatment and its 
effect on time to treatment, results of included randomized 
and nonrandomized studies in our analysis varied between a 
significant positive effect or a significant negative effect of 
local anesthesia or conscious sedation and a nonsignificant 
difference compared with general anesthesia. By combining 
these results in a meta-analysis, we showed a potential posi-
tive effect of nongeneral anesthesia on workflow.
The favorable effect of reducing time to treatment on func-
tional outcome as described in previous studies is confirmed 
by our study.4,66 Analysis of 5 endovascular stroke treatment 
trials showed a 4% absolute risk difference for a good func-
tional outcome per hour of delay between symptom onset and 
reperfusion.4 Our meta-analysis showed a difference in time to 
treatment effect of 26 minutes, with a total absolute risk dif-
ference of good functional outcome of 12%, which is higher 
compared with the ≈2% absolute risk difference per half hour 
as seen in the meta-analysis of 5 endovascular stroke treat-
ment trials. However, selection bias could have occurred in 
the nonrandomized studies included in our meta-analysis and 
differences in baseline characteristics might have influenced 
our results. The effect of time to treatment on functional out-
come might be stronger in clinical practice compared with a 
selected patient population from randomized controlled tri-
als.67 Furthermore, some workflow improvements, such as an-
esthetic management, have an effect on functional outcome 
which is not completely explained by the difference in time 
to treatment.1
A meta-analysis of 5 large endovascular stroke trials 
showed no effect of time to treatment on rates of mortality 
and symptomatic intracranial hemorrhage.4 Our study showed 
no difference in rate of symptomatic intracranial hemorrhage, 
but significantly lower mortality among patients in the inter-
vention group. However, possible selection bias in the non-
randomized studies included in our meta-analysis could have 
influenced the effect of time to treatment on mortality.
This study has several limitations. To perform the meta-
analysis, we estimated the mean time to treatment for 8 stud-
ies using the median time to treatment, interquartile range, 
and sample size. Because the meta-analysis is aimed at the 
difference in time to treatment between groups, rather than 
the actual time intervals per group, we assume that using 
the estimation of the mean time to treatment has no signifi-
cant effect on the primary outcome. Considerable heteroge-
neity between included studies was observed. Therefore, we 
used a random-effects inverse variance model for our meta-
analysis and categorized the interventions to perform sepa-
rate analyses for each intervention type. Forty-eight of 51 
included studies used a nonrandomizing study design, with a 
high risk of selection bias. Furthermore, most data were col-
lected retrospectively in a single center, without blinding of 
personnel and participants, possibly leading to performance 
bias. Multiple prepost intervention studies were included in 
our meta-analysis, in which learning effect over time can 
also effect time to treatment. Therefore, generalizability is 
Table 3. Random-Effects Meta-Analysis of Difference in Mean Time to Treatment 








Difference, min (95% 
CI)
All interventions 47 3480/4002 26 (19–32); P<0.001
Anesthetic 
management
23 2283/2445 12 (6–17); P<0.001
Prehospital 
management




13 730/1150 41 (27–54); P<0.001
Teamwork 7 502/708 47 (228–67); P<0.001




8 531/735 50 (31–69); P<0.001
Figure 3. Funnel plot to detect potential publication bias in 43 studies of 
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difficult to assess for the individual studies. However, be-
cause we included multiple studies on the same subject, 
these results can give us valuable insight on the possible 
effects in general practice, which is very promising. One of 
the purposes of a systematic review is to identify gaps in 
our knowledge and point out clinical areas that would ben-
efit from more research. The 7 subcategories of prehospital 
intervention with only a limited number of studies suggest 
that more work can be done in this area. Intervention stud-
ies and modeling of prehospital workflow may provide more 
insights, and effective prehospital management strategies 
may have a relatively large effect on outcome.
In conclusion, interventions in the workflow of endovas-
cular stroke treatment lead to a significant reduction in time 
to treatment. Reduction of any delay in time to treatment, 
by workflow interventions aimed at any interval between 
symptom onset and treatment, leads to a higher chance of 
good functional outcome for each individual patient. Acute 
stroke care should be reorganized by making use of the 
examples of workflow interventions described in this review 
to ensure the best medical care for patients with acute is-
chemic stroke.
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